Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 145.5B | 137.5B | 121.8B | 131.0B |
Cost of revenue | 135.2B | 127.5B | 110.1B | 123.4B |
Gross profit | 10.3B | 10.0B | 11.8B | 7.6B |
Operating expense | ||||
Research & development | 729.3M | 802.5M | 588.9M | 185.0M |
Selling general and admin | 1.5B | 537.6M | 988.4M | 924.5M |
Other operating expenses | 1.3B | 968.5M | 1.2B | 479.5M |
Operating income | 6.6B | 6.6B | 9.0B | 6.0B |
Non operating interest income | ||||
Income | 171.5M | 195.9M | 116.0M | 72.7M |
Expense | 809.7M | 1.0B | 526.6M | 722.2M |
Other income expense | — | — | — | — |
Pretax income | 5.5B | 5.4B | 7.3B | 4.5B |
Tax provision | 1.7B | 1.6B | 2.1B | 1.0B |
Net income | 3.8B | 3.8B | 5.3B | 3.5B |
Basic EPS | 0.2 | 0.2 | 0.3 | 0.3 |
Diluted EPS | 0.2 | 0.2 | 0.3 | 0.3 |
Basic average shares | 12.8B | 12.9B | 12.7B | 10.7B |
Diluted average shares | 12.8B | 12.9B | 12.7B | 10.7B |
EBITDA | 9.8B | 10.2B | 11.2B | 8.4B |
Net income from continuing op. | 3.8B | 3.8B | 5.3B | 3.5B |
Minority interests | -1.0B | -1.1B | -1.1B | -369.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |